NON-VITAMIN K oral anticoagulants (NOACs - formerly 'novel oral anticoagulants') have been shown to prove their worth in a large Italian study where vitamin K anticoagulant (VKA - eg warfarin) therapy was the norm.
The research involving data from 137,800 patients showed NOACs had a positive impact in terms of safety and effectiveness especially by lowering intracranial bleeding.
CLICK HERE for the study.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Oct 17
